These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

391 related items for PubMed ID: 16360897

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Low-molecular-weight heparin in cancer-associated thrombosis: treatment, secondary prevention, and survival.
    Nishioka J, Goodin S.
    J Oncol Pharm Pract; 2007 Jun; 13(2):85-97. PubMed ID: 17873108
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The role of low-molecular-weight heparins as supportive care therapy in cancer-associated thrombosis.
    Cunningham RS.
    Semin Oncol; 2006 Apr; 33(2 Suppl 4):S17-25; quiz S41-2. PubMed ID: 16638457
    [Abstract] [Full Text] [Related]

  • 7. Heparin and low-molecular-weight heparin therapy for venous thromboembolism. The twilight of anticoagulant monitoring.
    Hull RD, Pineo GF, Stein P.
    Int Angiol; 1998 Dec; 17(4):213-24. PubMed ID: 10204652
    [Abstract] [Full Text] [Related]

  • 8. Low-molecular-weight heparin or oral anticoagulation for secondary prevention of deep vein thrombosis in cancer patients.
    Levine M.
    Semin Thromb Hemost; 2003 Dec; 29 Suppl 1():9-11. PubMed ID: 14730472
    [Abstract] [Full Text] [Related]

  • 9. Treatment of cancer-associated thrombosis: distinguishing among antithrombotic agents.
    Pruemer J.
    Semin Oncol; 2006 Apr; 33(2 Suppl 4):S26-39; quiz S41-2. PubMed ID: 16638458
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A review of the practical advantages of low molecular weight heparin in the treatment of cancer-related venous thromboembolism.
    Rhodes S, Bond S.
    Eur J Oncol Nurs; 2008 Dec; 12(5):425-9. PubMed ID: 18842458
    [Abstract] [Full Text] [Related]

  • 12. Low-molecular-weight heparin in outpatient treatment of DVT.
    Yeager BF, Matheny SC.
    Am Fam Physician; 1999 Feb 15; 59(4):945-52. PubMed ID: 10068716
    [Abstract] [Full Text] [Related]

  • 13. Treatment of pulmonary embolism: The use of low-molecular-weight heparin in the inpatient and outpatient settings.
    Hull RD.
    Thromb Haemost; 2008 Mar 15; 99(3):502-10. PubMed ID: 18327398
    [Abstract] [Full Text] [Related]

  • 14. [Treatment of venous thrombosis in cancer patients: practical aspects].
    Laza-Achille M, Desruennes E, Di Palma M.
    Bull Cancer; 2006 Mar 01; 93(3):271-81. PubMed ID: 16567314
    [Abstract] [Full Text] [Related]

  • 15. Management of thrombosis in cancer: primary prevention and secondary prophylaxis.
    Lee AY.
    Br J Haematol; 2005 Feb 01; 128(3):291-302. PubMed ID: 15667530
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prevention of deep vein thrombosis in cancer patients.
    Lee AY.
    Semin Thromb Hemost; 2007 Oct 01; 33(7):699-706. PubMed ID: 18000798
    [Abstract] [Full Text] [Related]

  • 18. NCCN issues first guidelines for deep vein thrombosis treatment in cancer patients.
    Susman E.
    J Natl Cancer Inst; 2006 Apr 19; 98(8):515. PubMed ID: 16622119
    [No Abstract] [Full Text] [Related]

  • 19. The optimal long-term treatment of venous thromboembolism.
    Prandoni P.
    Clin Adv Hematol Oncol; 2004 Nov 19; 2(11):729-32. PubMed ID: 16170889
    [No Abstract] [Full Text] [Related]

  • 20. Low-molecular-weight heparin for thromboprophylaxis.
    Camporese G, Bernardi E.
    Curr Opin Pulm Med; 2009 Sep 19; 15(5):443-54. PubMed ID: 19593139
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.